Patent · US Active

Compounds having CRTH2 antagonist activity

US8980927B2 · kind B2 · utility

3Cited by
35References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 7, 2013
Grant dateMar 17, 2015
Priority date—
Expiry dateOct 12, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of general formula (II)wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.